Line 288: | Line 288: | ||
<br>• PCR: #1, #2, #3, #4, #6, #15, #18, #20, #23, #24, #25, #26</br> | <br>• PCR: #1, #2, #3, #4, #6, #15, #18, #20, #23, #24, #25, #26</br> | ||
Each PCR was loaded on a preparative gel and cut out before undergoing PCR-purification. | Each PCR was loaded on a preparative gel and cut out before undergoing PCR-purification. | ||
− | <br><br>• Golden Gate Assembly: BB1_09, BB1_10, BB1_11, BB1_12, BB1_13, BB2_01 (unsuccessful), BB2_02, BB2_03, BB2_04, BB2_05 (unsuccessful)</br> | + | <br><br>• Golden Gate Assembly: <a href="#BB1_09" class="bgscroll"> BB1_09</a>, <a href="#BB1_10" class="bgscroll"> BB1_10</a>, <a href="#BB1_11" class="bgscroll"> BB1_11</a>, <a href="#BB1_12" class="bgscroll"> BB1_12</a>, <a href="#BB1_13" class="bgscroll"> BB1_13</a>, BB2_01 (unsuccessful), <a href="#BB2_02" class="bgscroll"> BB2_02</a>, <a href="#BB2_03" class="bgscroll"> BB2_03</a>, <a href="#BB2_04" class="bgscroll"> BB2_04</a>, BB2_05 (unsuccessful)</br> |
+ | |||
+ | <div id="BB1_09" class="modalDialog modal-lg"> | ||
+ | <div><a href="#close" title="Close" class="close">X</a> | ||
+ | <img src="https://static.igem.org/mediawiki/2017/1/1a/T--BOKU-Vienna--BB109.png" style="width:100%;height:auto;"/> | ||
+ | </div></div> | ||
+ | <div id="BB1_10" class="modalDialog modal-lg"> | ||
+ | <div><a href="#close" title="Close" class="close">X</a> | ||
+ | <img src="https://static.igem.org/mediawiki/2017/5/55/T--BOKU-Vienna--BB110.png" style="width:100%;height:auto;"/> | ||
+ | </div></div> | ||
+ | <div id="BB1_11" class="modalDialog modal-lg"> | ||
+ | <div><a href="#close" title="Close" class="close">X</a> | ||
+ | <img src="https://static.igem.org/mediawiki/2017/e/e4/T--BOKU-Vienna--BB111.png" style="width:100%;height:auto;"/> | ||
+ | </div></div> | ||
+ | <div id="BB1_12" class="modalDialog modal-lg"> | ||
+ | <div><a href="#close" title="Close" class="close">X</a> | ||
+ | <img src="https://static.igem.org/mediawiki/2017/5/59/T--BOKU-Vienna--BB112.png" style="width:100%;height:auto;"/> | ||
+ | </div></div> | ||
+ | <div id="BB1_13" class="modalDialog modal-lg"> | ||
+ | <div><a href="#close" title="Close" class="close">X</a> | ||
+ | <img src="https://static.igem.org/mediawiki/2017/b/bf/T--BOKU-Vienna--BB113.png" style="width:100%;height:auto;"/> | ||
+ | </div></div> | ||
+ | <div id="BB2_02" class="modalDialog modal-lg"> | ||
+ | <div><a href="#close" title="Close" class="close">X</a> | ||
+ | <img src="https://static.igem.org/mediawiki/2017/b/bd/T--BOKU-Vienna--BB202.png" style="width:100%;height:auto;"/> | ||
+ | </div></div> | ||
+ | <div id="BB2_03" class="modalDialog modal-lg"> | ||
+ | <div><a href="#close" title="Close" class="close">X</a> | ||
+ | <img src="https://static.igem.org/mediawiki/2017/3/3b/T--BOKU-Vienna--BB203.png" style="width:100%;height:auto;"/> | ||
+ | </div></div> | ||
+ | <div id="BB2_04" class="modalDialog modal-lg"> | ||
+ | <div><a href="#close" title="Close" class="close">X</a> | ||
+ | <img src="https://static.igem.org/mediawiki/2017/c/cc/T--BOKU-Vienna--BB204.png" style="width:100%;height:auto;"/> | ||
+ | </div></div> | ||
+ | |||
GG-products are then transformed into competent cells. Colonies with specific antibiotic resistances were selected out by using antibiotic-containing media. The next day, positives clones were confirmed via a OneTaq colony PCR and a gel electrophoresis before a Miniprep was made.</br> | GG-products are then transformed into competent cells. Colonies with specific antibiotic resistances were selected out by using antibiotic-containing media. The next day, positives clones were confirmed via a OneTaq colony PCR and a gel electrophoresis before a Miniprep was made.</br> | ||
<br>• pSIM5 pre-cultures (DH5alpha + BL21(DE3))</br> | <br>• pSIM5 pre-cultures (DH5alpha + BL21(DE3))</br> | ||
Line 311: | Line 345: | ||
Each PCR was loaded on a preparative gel and cut out before undergoing PCR-purification. | Each PCR was loaded on a preparative gel and cut out before undergoing PCR-purification. | ||
<br><br>• Golden Gate Assembly: BB1_16, BB1_17, BB1_18, BB1_20, BB1_21, BB1_22, BB1_23, BB1_24, BB1_25, BB2_17, BB2_23, BB2_24, BB3_01 (unsuccessful), BB3_02, , BB3_04, BB3_05, BB3_06 (doubtful), BB3_08</br> | <br><br>• Golden Gate Assembly: BB1_16, BB1_17, BB1_18, BB1_20, BB1_21, BB1_22, BB1_23, BB1_24, BB1_25, BB2_17, BB2_23, BB2_24, BB3_01 (unsuccessful), BB3_02, , BB3_04, BB3_05, BB3_06 (doubtful), BB3_08</br> | ||
+ | |||
+ | |||
GG-products are then transformed into competent cells. Colonies with specific antibiotic resistances were selected out by using antibiotic-containing media. The next day, positives clones were confirmed via a OneTaq colony PCR and a gel electrophoresis before a Miniprep was made.</br> | GG-products are then transformed into competent cells. Colonies with specific antibiotic resistances were selected out by using antibiotic-containing media. The next day, positives clones were confirmed via a OneTaq colony PCR and a gel electrophoresis before a Miniprep was made.</br> | ||
<br>• Yeast S266C made electro-competent</br> | <br>• Yeast S266C made electro-competent</br> |
Revision as of 15:23, 29 October 2017
Notebook.
All protocols we used for the methods can be found here:
Protocol
For further information regarding our Golden Gate Assembly products, please refer to our part collection site.
Week 1 (03/07-07/07)
Week 2 (10/07-14/07)
Week 3 (17/07-21/07)
Week 4 (24/07-28/07)
Week 5 (31/07-04/08)
Week 6 (07/08-11/08)
Week 7 (14/08-18/08)
Week 8 (21/08-25/08)
Week 9 (28/08-01/09)
Week 10 (04/09-08/09)
Week 11 (11/09-15/09)
Week 12 (18/09-22/09)
Week 13 (25/09-29/09)